Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Gharam M. Alazmi"'
Autor:
Mohammad M. Al-Sanea, Garri Chilingaryan, Narek Abelyan, Grigor Arakelov, Harutyun Sahakyan, Vahram G. Arakelov, Karen Nazaryan, Shaimaa Hussein, Gharam M. Alazmi, Haifa E. Alsharari, Waad M. Al-faraj, Faten S. Alruwaili, Nouf Q. Albilasi, Tahani S. Alsharari, Abdulaziz A. S. Alsaleh, Turki M. Alazmi, Atiah H. Almalki, Nasser H. Alotaibi, Mohamed A. Abdelgawad
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
Abstract Human carbonic anhydrase XII (hCA XII) isozyme is of high therapeutic value as a pharmacological target and biomarker for different types of cancer. The hCA XII is one of the crucial effectors that regulates extracellular and intracellular p
Externí odkaz:
https://doaj.org/article/2c1d4ac6a4d343049a08b2c705fe9f50
Autor:
Haifa E. Alsharari, Nasser Hadal Alotaibi, Mohamed A. Abdelgawad, Grigor Arakelov, Nouf Q. Albilasi, Mohammad M. Al-Sanea, Narek Abelyan, Harutyun Sahakyan, Vahram Arakelov, Abdulaziz A. S. Alsaleh, Atiah H. Almalki, Gharam M. Alazmi, Turki M. Alazmi, Garri Chilingaryan, Shaimaa Hussein, Faten S. Alruwaili, Karen Nazaryan, Tahani S. Alsharari, Waad M. Al-faraj
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
Scientific Reports
Scientific Reports
Human carbonic anhydrase XII (hCA XII) isozyme is of high therapeutic value as a pharmacological target and biomarker for different types of cancer. The hCA XII is one of the crucial effectors that regulates extracellular and intracellular pH and aff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::952b361447b36e610a68f936d1af5f91
https://doaj.org/article/2c1d4ac6a4d343049a08b2c705fe9f50
https://doaj.org/article/2c1d4ac6a4d343049a08b2c705fe9f50
Autor:
Gharam M. Alazmi, Mohammad M. Al-Sanea, Turki M. Alazmi, Grigor Arakelov, Shaimaa Hussein, Nouf Q. Albilasi, Vahram Arakelov, Atiah H. Almalki, Tahani S. Alsharari, Narek Abelyan, Harutyun Sahakyan, Nasser Hadal Alotaibi, Mohamed A. Abdelgawad, Haifa E. Alsharari, Faten S. Alruwaili, Abdulaziz A. S. Alsaleh, Waad M. Al-faraj, Garri Chilingaryan
Human carbonic anhydrase XII (hCA XII) has gained therapeutic value in the field of medicinal chemistry as a pharmacological target and biomarker for different types of cancer. Despite the fact that interaction features of hCAs inhibitors with the ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::463c95ce6b6076cc2ebbb30782adbc2b
https://doi.org/10.21203/rs.3.rs-394808/v1
https://doi.org/10.21203/rs.3.rs-394808/v1
